3 employees
Epiphany Biosciences develops therapeutic products and diagnostic technologies that can prevent or cure the spread of pathogenic viruses.
1998
$36M
from 1 investors over 1 rounds
Epiphany Biosciences raised $36M on March 16, 2007
Investors: Wexford Capital LP